Search clinical trials for: Thromboembolic event

Total 3050 results

Medical University of Vienna

Recruiting

Comparing Anticoagulation Strategies Using UFH, Argatroban and LMWH for ECMO Support (CASUAL-ECMO)

Respiratory Insufficiency | Bleeding | Thromboembolism | Circulatory Failure

Austria
Beijing Tiantan Hospital

Recruiting

Tirofiban for Reduction of Thromboembolic Events in Endovascular Unruptured Aneurysm Repair (TEAR)

Unruptured Intracranial Aneurysm | Thromboembolic Events | Flow Diverter | Stent-assisted Coiling

China
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Effect of a Global Simplified Strategy on Thromboembolic Events in Emergency Department Patients With Suspected Pulmonary Embolism (MODS STRATEGY)

Pulmonary Embolism
Institut universitaire de cardiologie et de pneumologie...

Not yet recruiting

Recurrent or Persistent Device Related Thrombus After Left Atrial Appendage Occlusion: The RE-DRT Study (RE-DRT)

Thromboembolic Event | Percutaneous Left Atrial Appendage Occlusion (LAAO) | Device-related Thrombus (DRT) | Major Cardioembolic Events | Major Bleeding - TIMI Classification
St. Antonius Hospital
ZonMw: The Netherlands Organisation for Health Research and Development; Pitié-Salpêtrière...

Recruiting

Personalized, CT-guided Antithrombotic Therapy Versus Lifelong Single Antiplatelet Therapy to Reduce Thromboembolic and Bleeding Events in Non-atrial Fibrillation Patients After Transcatheter Aortic Valve Implantation (POP ATLANTIS)

Severe Aortic Valve Stenosis

Netherlands
Institut Cancerologie de l'Ouest
Diagnostica Stago

Recruiting

Thrombin Generation and Prediction of Thromboembolic Events in Oncology Patients at Risk (THROMBIN)

Solid Carcinoma

France
Centre Hospitalier Universitaire de Saint Etienne
Ministry of Health, France

Recruiting

Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking Antiplatelets (BAT-VTE)

Venous Thromboembolic Disease

France
Galician Research Group on Digestive Tumors
LEO Pharma

Recruiting

TINzaparin Prophylaxis in Patients With Metastatic Colorectal Cancer (PROTINCOL)

Thromboembolism | Colorectal Cancer Metastatic

Spain
Scientific Institute San Raffaele

Recruiting

Platelet Function and Neurological Events (MULTINEUR)

Carotid Artery Diseases | Stroke, Acute

Italy
Novartis Pharmaceuticals

Recruiting

Study to Identify and Describe Predictive Factors for Thromboembolic Events in Patients With High-risk Polycythemia Vera (Prospero)

Polycythemia Vera

Italy
Anthos Therapeutics, Inc.
CYTE Global

Recruiting

Study in Atrial Fibrillation (AF) Patients at High Risk of Stroke (GARDENIA)

Atrial Fibrillation

United States, Czechia, Poland, Spain, Germany, Canada, Hungary, United Kingdom, Argentina, Italy, Brazil, Mexico
Fundación de Investigación Biomédica - Hospital...

Recruiting

Effect of Tofacitinib on Coagulation and Platelet Function, and Its Role in Thromboembolic Events

Ulcerative Colitis | Thromboembolism

Spain
University Hospital Inselspital, Berne

Recruiting

LAAC-registry: Clinical Outcome After Echocardiography-guided LAA-closure

Cardiovascular Diseases | Atrial Fibrillation | Thromboembolism

Switzerland
Leiden University Medical Center
Medtronic - MITG

Recruiting

Leiden Trial In Prevention of Post-Operative ThromboEmbolic Events (TIPOTEE)

Deep-Venous Thrombosis

Netherlands
Registro Mexicano Multidisciplinario De Pacientes...
Webmedica

Not yet recruiting

Mexican Multidisciplinary Registry of Patients With Venous Thromboembolic Disease (REMMITE)

Venous Thrombosis | Venous Thromboembolism | Pulmonary Embolism
Oregon Health and Science University

Recruiting

Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)

Trauma | Surgery | Deep Vein Thrombosis (DVT) | Thromboembolic Events

United States
CHU de Reims

Completed

Elaboration of a Prioritization Score for Pharmaceutical Interviews in Patients Treated With Oral Anticoagulants

Thromboembolic Event

France
Fred Hutchinson Cancer Center
University of California, San Diego; National Heart, Lung, and Blood Institute... and other collaborators

Active, not recruiting

Women's Health Initiative Strong and Healthy Study (WHISH)

Myocardial Infarction | Stroke | Mortality | Sleep | Depressive Symptoms | Hip Fractures | Peripheral Artery Disease | Falls | Physical Function | Cardiovascular Mortality | Coronary Revascularization | Venous Thromboembolic Event | Mobility and Independence | Clinical (Non-hip) Fractures
Bayer

Completed

An Observational Study (Called RETAF-PS) Using a Patient Survey to Learn More About Treatment Outcomes in Patients With Irregular and Often Rapid Heartbeat (Atrial Fibrillation) Treated With Apixaban in a Real World Setting

Atrial Fibrillation | Prevention of Thromboembolic Events

United States
Centre Hospitalier Universitaire de Saint Etienne

Completed

Cancer Associated Thrombosis : What is the Proportion of Patients Ineligible to a Study as CARAVAGGIO

Cancer | Venous Thromboembolism

France
Bayer

Completed

A Study to Learn How the Study Treatment Asundexian Moves Into, Through and Out of the Body, How it Works, How Safe it is, and How it Affects the Body in Participants With Mild or Moderate Reduction of Liver Function Compared to Participants With Normal Liver Function

Atrial Fibrillation | Hepatic Impairment | Acute Myocardial Infarction | Prevention of Thromboembolic Events | Non-cardioembolic Ischemic Stroke

Germany
Portola Pharmaceuticals

Completed

Factor Xa Inhibitor, PRT054021, Against Enoxaparin for the Prevention of Venous Thromboembolic Events (EXPERT)

Thromboembolism

Canada
Bayer

Completed

Study to Investigate the Safety of a Drug Called Osocimab at Low and High Doses in Adult Patients With Kidney Failure Requiring Regular Hemodialysis (CONVERT)

Hemodialysis | End-stage Renal Disease | Hemodiafiltration | Prevention of Thromboembolic Events

Spain, Greece, Belgium, Russian Federation, Netherlands, Turkey, Japan, Australia, Austria, Bulgaria, Italy, Ukraine, Czechia, Israel, United States, Hungary, Lithuania, Poland, Portugal
Arianna Anticoagulazione Foundation

Completed

Baseline Concentration of Direct Oral Anticoagulant and Incidence of Adverse Event Measure And See (MAS) (MAS)

Atrial Fibrillation | Anticoagulant-induced Bleeding

Italy
Memorial Sloan Kettering Cancer Center
Halozyme Therapeutics; Miami Cancer Institute

Active, not recruiting

Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma

Pancreatic Cancer | Advanced Pancreatic Ductal Adenocarcinoma

United States
Vanderbilt University Medical Center

Terminated

Lavare Cycle in Patients Receiving HeartWare Left Ventricular Assist Device

Stroke | Hemolysis | Thromboembolism

United States
Instituto Mexicano del Seguro Social

Completed

Rivaroxaban Plus Aspirin to Manage Recurrent Venous Thromboembolic Events

Venous Thromboembolism | Pulmonary Embolism | Anticoagulant-induced Bleeding | Venous Thromboses

Mexico
Daiichi Sankyo, Inc.

Completed

Edoxaban for Prevention of Blood Vessels Being Blocked by Clots (Thrombotic Events) in Children at Risk Because of Cardiac Disease

Cardiac Disease

United States, Spain, Canada, Lebanon, Turkey, Austria, Croatia, Egypt, France, Hungary, India, Israel, Ukraine, United Kingdom
Karolinska Institutet
Aarhus University Hospital; Rigshospitalet, Denmark; Linkoeping University; Aalborg... and other collaborators

Completed

The Effect of Dexamethasone 12 mg vs 6 mg on Thromboembolic Events in Patients With Critical COVID-19

COVID-19 | Bleeding | Thrombosis Embolism

Sweden
Andres muñoz
Hospital Clinic of Barcelona; LEO Pharma; Hospital General Universitario Elche; Hospital Universitario Ramon y Cajal and other collaborators

Completed

A New Clinic-Genetic Risk Score for Predicting Venous Thromboembolic Events in Cancer Patient (ONCOTHROMB)

Genetic Predisposition | Cancer-associated Thrombosis

Spain
Bayer

Completed

Study to Assess the Safety, Tolerability, Effects on the Body, Absorption, Distribution and Elimination of 25 mg BAY2433334 in Renal Impairment Including Renal Replacement Therapy ("Dialysis")

Prevention of Thromboembolic Events

Germany
Centro Hospitalar Tondela-Viseu
Portuguese IBD Group

Completed

Inflammatory Bowel Disease and Thromboembolic Events

Inflammatory Bowel Diseases | Coagulation Disorder | Thromboembolism

Portugal
Pfizer

Withdrawn

A Study of Adverse Events and Suspected Adverse Drug Reactions in Patients Under Apixaban for Prevention of Stroke and Systemic Embolism With Non-Valvular Atrial Fibrillation and Venous Thromboembolic Events in Patients Who Have Undergone Elective Hip or Knee Replacement Surgery

Pulmonary Embolism | Cerebral Stroke | Thrombosis, Deep Vein
Les Laboratoires des Médicaments Stériles

Completed

Comparison of Thromboembolic Events in Patients Undergoing Thromboprophylactic Treatment With ENOXA® vs Lovenox® (ENOXACARE)

Gastrointestinal Neoplasms | Thromboembolic Event

Tunisia
CSL Behring
Kaiser Permanente

Completed

An Observational Cohort Study to Investigate the Risk of Thromboembolic Events in Patients Receiving Kcentra® or Plasma to Reverse Vitamin K Antagonist (VKA) Therapy in the Setting of Acute Major Bleeding

Hemorrhage

United States
Thrombosis Research Institute
Bayer

Completed

Global Anticoagulant Registry in the FIELD- Venous Thromboembolic Events (GARFIELD-VTE)

Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism

United States
Centre Hospitalier Universitaire de Saint Etienne

Completed

Predictors of Attempted Inferior Vena Cava Filters Retrieval.

Venous Thromboembolic Disease

France
Jeffrey Zwicker, MD
National Heart, Lung, and Blood Institute (NHLBI); Quercegen Pharmaceuticals

Completed

Cancer Associated Thrombosis and Isoquercetin (CATIQ) (CATIQ)

Thromboembolism of Vein VTE in Colorectal Cancer | Thromboembolism of Vein in Pancreatic Cancer | Thromboembolism of Vein in Non-small Cell Lung Cancer

United States
Rigshospitalet, Denmark

Completed

Frequency of Vascular Events With Short-term Thromboprophylaxis in Fast-track Hip and Knee-arthroplasty. (FETA)

Thromboembolic Events | Post-operative Bleeding

Denmark
Assistance Publique - Hôpitaux de Paris

Unknown

Evaluation of NETs in Patients With Solid Cancers Associated With a High Risk of Venous Thromboembolic Events (Flownet)

Gastric Cancer | Colorectal Cancer | Pancreatic Cancer

France
Novartis Pharmaceuticals

Withdrawn

Prevention of Thromboembolic Events in Total Knee Replacement Patients

Thrombotic Disorders
Novartis Pharmaceuticals

Withdrawn

Efficacy and Safety of MAA868 in Patients With Atrial Fibrillation

Atrial Fibrillation
Chiesa Alessandro Felice

Completed

Prevalence and Risk Factors for Venous Thromboembolic Events in Critically Ill Patients With COVID-19

SARS Virus

Switzerland
Atrial Fibrillation Network

Completed

Prospective Registration and Assessment of Serious Adverse Events Within the AFNET (AFNET A7)

Atrial Fibrillation | Assessment of Serious Advers Events | Thromboembolic and Bleeding Complications | Complications of Antiarrhythmic Drugs or Invasive Procedures | Assessment by a Critical Event Committee

Germany
Assistance Publique - Hôpitaux de Paris
Bristol-Myers Squibb; Daiichi Sankyo, Inc.

Terminated

Oral Anticoagulant Peri-procedural Management in Patients Undergoing an Oral Surgery, Implantology or Periodontology (PRADICO)

Invasive Procedure | Oral Anticoagulants

France
Karolinska Institutet

Completed

Anticoagulant Therapy and 28-days Mortality in Critically Ill COVID-19 Patients

Covid-19 | Bleeding | Thromboembolic Events

Sweden
Thomas Guerrero

Completed

Non-Contrast 4DCT to Detect Pulmonary Thromboembolic Events

Pulmonary Embolism | Pulmonary Thromboembolisms

United States
University Hospital, Strasbourg, France

Unknown

Thromboembolic Events in Severe COVID-19 Patients (COVICLOT)

Pulmonary Thromboembolism

France
Institut de Cancérologie de la Loire
Centre Hospitalier Universitaire de Saint Etienne; CH Roanne

Completed

Radiation Impact on Thromboembolic Events (RIT)

Malignant Neoplasm

France
Academisch Medisch Centrum - Universiteit van Amsterdam...

Completed

Venous Thromboembolism and Bleeding Risk in Patients With Esophageal Cancer (VENETIA)

Bleeding | Venous Thromboembolism | Chemotherapy Effect | Esophagus Cancer

Netherlands

Search clinical trials for: Thromboembolic event

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritius

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations